Skip to main content Help with accessibility Skip to main navigation

Ulipristal acetate

Indication

Pre-surgical treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

MHRA Aug 2018 Update - Ulipristal

Drug Safety Update March 2020 - Esmya (ulipristal acetate): suspension of the licence due to risk of serious liver injury

Black

Brand:

Esmya

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Genito-urinary system

Background

Recommendation

LSCMMG Recommendation:

Black

Reason for decision:

Not recommended for prescribing on the NHS in Lancashire & South Cumbria

Supporting documents:

Decisions of Lancashire local decision making groups

Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending
What do the colours mean?

Last Updated: 01 - Sep - 2018